
Pfizer Flags Softer 2026 Outlook as COVID Revenue Continues to Fade
Pfizer Lowers Earnings Outlook for 2026 Pfizer signaled continued pressure on its post-pandemic business, forecasting 2026 profit below analyst expectations as demand for COVID-related products continues to normalize. The drugmaker said it expects adjusted earnings of $2.80 to $3.00 per





